Anti-CD3 Therapy
(Journal Article): Questioning Four Preconceived Ideas on Immunotherapy of Clinical Type 1 Diabetes: Lessons from Recent CD3 Antibody Trials
Chatenoud L, Bach JF
IN:
Rev Diabetic Stud
2005; 2(3):116-120
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
ABSTRACT:
n.a.
Click HERE for details
(Journal Article): Insulin-dependent diabetes mellitus as an autoimmune disease.
Bach JF
IN:
Endocr Rev
1994; 15(4):516-542
Impact Factor(s) of Endocr Rev: 18.784 (2004), 17.324 (2003), 21.643 (2002), 26.456 (2001)
ABSTRACT:
IDDM is unquestionably an autoimmune disease, as reflected by the presence of beta-cell-reactive autoantibodies and T cells, T cell-mediated transfer of the disease in nondiabetic ...
Click HERE for details
(Journal Article): Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach
Bresson D, von Herrath M
IN:
Rev Diabetic Stud
2005; 20(4):187-189
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
ABSTRACT:
n.a.
Click HERE for details
(Journal Article): Response to the Comment by D. Bresson and M. von Herrath
Chatenoud L, Bach JF
IN:
Rev Diabetic Stud
2005; 2(4):190-191
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
ABSTRACT:
n.a.
Click HERE for details
|
| Contribute
to this subject area!
|
|
|
